Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001642833-20-000003)

Filing Details

Accession Number:
0001642833-20-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-07 20:51:39
Reporting Period:
2020-08-05
Accepted Time:
2020-08-07 20:51:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628908 Evolent Health Inc. EVH Services-Management Services (8741) 320454912
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1642833 Jonathan Weinberg C/O Evolent Health, Inc.
800 N. Glebe Road, Suite 500
Arlington VA 22203		 General Counsel No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2020-08-05 10,000 $3.84 76,775 No 4 M Direct
Class A Common Stock Disposition 2020-08-05 10,000 $13.01 66,775 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Class A Common Stock Option (right to buy) Disposition 2020-08-05 10,000 $0.00 10,000 $3.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,431 2024-04-01 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2020.
  2. Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.000 to $13.015, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  4. The Class A Common Stock Options exercised vested on February 1, 2017.